Pharmaceutical toxicology: Designing studies to reduce animal use, while maximizing human translation
Immunoaffinity nanogold coupled with direct analysis in real time (DART) mass spectrometry for analytical toxicology - Analytical Methods (RSC Publishing)
![Developmental and Reproductive Toxicology (DART) - HESI - Health and Environmental Sciences Institute Developmental and Reproductive Toxicology (DART) - HESI - Health and Environmental Sciences Institute](https://hesiglobal.org/wp-content/uploads/2020/08/DART_resize.jpg)
Developmental and Reproductive Toxicology (DART) - HESI - Health and Environmental Sciences Institute
![DART - "Developmental And Reproductive Toxicology (database / base de données)" by AcronymsAndSlang.com DART - "Developmental And Reproductive Toxicology (database / base de données)" by AcronymsAndSlang.com](http://acronymsandslang.com/acronym_image/633/6ead217cc3b7a550644955d294c7abda.jpg)
DART - "Developmental And Reproductive Toxicology (database / base de données)" by AcronymsAndSlang.com
![Developmental And Reproductive Toxicology (DART) Studies What Are They And How Do They Fit Into Your Program Developmental And Reproductive Toxicology (DART) Studies What Are They And How Do They Fit Into Your Program](http://vertassets.blob.core.windows.net/image/8e01909d/8e01909d-4c21-4851-8c71-5202214242d9/toxicology.jpg)
Developmental And Reproductive Toxicology (DART) Studies What Are They And How Do They Fit Into Your Program
![Developmental and Reproductive Toxicology (DART) - HESI - Health and Environmental Sciences Institute Developmental and Reproductive Toxicology (DART) - HESI - Health and Environmental Sciences Institute](https://hesiglobal.org/wp-content/uploads/2023/03/DART-Professional-Dev-Award-300x300.png)
Developmental and Reproductive Toxicology (DART) - HESI - Health and Environmental Sciences Institute
![Characterization of bone abnormalities from micro-CT images for evaluating drug toxicity in developmental and reproductive toxicology (DART) studies | Semantic Scholar Characterization of bone abnormalities from micro-CT images for evaluating drug toxicity in developmental and reproductive toxicology (DART) studies | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/292e6fa2f94676ace4176dc5130431103d06d04b/1-Figure1-1.png)
Characterization of bone abnormalities from micro-CT images for evaluating drug toxicity in developmental and reproductive toxicology (DART) studies | Semantic Scholar
![Carcinogenicity *General Toxicology **DART **Safety Pharmacology HighMedium Low Genetic Toxicity Pharmacokinetics Pharmacology Study Group Priority Study. - ppt download Carcinogenicity *General Toxicology **DART **Safety Pharmacology HighMedium Low Genetic Toxicity Pharmacokinetics Pharmacology Study Group Priority Study. - ppt download](https://slideplayer.com/7205826/24/images/slide_1.jpg)
Carcinogenicity *General Toxicology **DART **Safety Pharmacology HighMedium Low Genetic Toxicity Pharmacokinetics Pharmacology Study Group Priority Study. - ppt download
![Considerations for Assessment of Reproductive and Developmental Toxicity of Oligonucleotide-Based Therapeutics | Nucleic Acid Therapeutics Considerations for Assessment of Reproductive and Developmental Toxicity of Oligonucleotide-Based Therapeutics | Nucleic Acid Therapeutics](https://www.liebertpub.com/cms/10.1089/nat.2014.0490/asset/images/medium/figure1.gif)
Considerations for Assessment of Reproductive and Developmental Toxicity of Oligonucleotide-Based Therapeutics | Nucleic Acid Therapeutics
![FDA Guidelines For Developmental and Reproductive Toxicology (DART) Studies for Small Molecules | Leaders in Pharmaceutical Business Intelligence (LPBI) Group FDA Guidelines For Developmental and Reproductive Toxicology (DART) Studies for Small Molecules | Leaders in Pharmaceutical Business Intelligence (LPBI) Group](https://i0.wp.com/pharmaceuticalintelligence.com/wp-content/uploads/2012/11/slide1.jpg?resize=500%2C375)